Key result
Transcatheter ASD closure at age ≥50 is linked to ~100% greater RV size reduction vs younger patients.
Why the study?
To assess the impact of transcatheter ASD closure on echocardiographic indices and compare outcomes between patients younger and older than 50 years.
Does transcatheter ASD closure improve echocardiographic indices differently in patients younger versus older than 50 years?
Cohort (n=240)
No
Does transcatheter ASD closure improve echocardiographic indices differently in patients younger versus older than 50 years?
Absolute Event Rate: 4% vs 2%
p-value: p=<0.001
Transcatheter ASD closure yields significant echocardiographic improvements in adults, with older patients (≥50 years) showing more pronounced structural and functional recovery than younger patients.
Echocardiographic recovery may be more pronounced in older adults; leaves open whether age modifies outcomes in randomized settings.
BACKGROUND: Transcatheter device closure is the method of choice for the closure of secundum atrial septal defects (ASD) with appropriate anatomic characteristics, leading to symptomatic relief, increased survival rates, cardiac remodeling, and improved cardiac function. OBJECTIVE: Assessing the impact of transcatheter ASD closure on echocardiographic indices and comparing them between individuals younger and older than 50. METHOD: In this retrospective cohort study, 240 patients with isolated secundum ASD and complete documentation and follow-up data who underwent transcatheter device closure between 2015 and 2019 were included. Demographic, peri-procedural, and echocardiographic findings were compared before and after the procedure and among two age groups. RESULTS: A total of 240 patients (68% female, 44% younger than 50) with a median age of 51 underwent transcatheter ASD closure. ASD closure led to a significant decline in the size of four cardiac chambers and systolic pulmonary arterial pressure (SPAP), in addition to a significant improvement in biventricular systolic function, LV diastolic function, and valvular insufficiencies. Although patients aged 50 and older had worse LV diastolic and RV systolic function, in addition to larger RV size and bi-atrial dimensions at the baseline, the extent of improvement of these parameters among them was significantly more pronounced than those younger than 50. There were no significant differences in the extent of the decline in SPAP between the two groups. CONCLUSION: Transcatheter ASD device closure is a beneficial procedure with high success rates and low complication rates among older individuals, eventually leading to improvements in cardiac form and function.
No takes yet. Share an insight, caveat, or question.
Kiani et al. (2025) conducted a cohort in Isolated secundum atrial septal defect (n=240). Transcatheter ASD device closure in patients aged ≥ 50 years vs. Transcatheter ASD device closure in patients aged < 50 years was evaluated on Reduction in right ventricular (RV) size (mm) (p=<0.001). Transcatheter ASD closure in patients aged 50 and older resulted in a significantly greater median reduction in right ventricular size (4 mm vs 2 mm, p<0.001) and more pronounced improvements in cardiac function compared to patients younger than 50.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: